{
  "meta": {
    "title": "Criterias_Mini_Test_-_Tmt",
    "url": "https://brainandscalpel.vercel.app/criterias-mini-test-tmt-7301d4e6.html",
    "scrapedAt": "2025-11-30T12:46:18.053Z"
  },
  "questions": [
    {
      "text": "Which of the following are not included among the minor criteria of the modified Duke criteria for the diagnosis of infective endocarditis?",
      "choices": [
        {
          "id": 1,
          "text": "Predisposing heart condition"
        },
        {
          "id": 2,
          "text": "Osler's nodes or Roth spots"
        },
        {
          "id": 3,
          "text": "Fever of >38.0°C (>100.4°F)"
        },
        {
          "id": 4,
          "text": "Single positive blood culture for Coxiella burnetii"
        }
      ],
      "correct_choice_id": 4,
      "solution": "<div class=\"page\" title=\"Page 1548\">\n<div class=\"section\">\n<div class=\"layoutArea\">\n<div class=\"column\">\n<p><strong>Single positive blood culture for Coxiella burnetii </strong>is one of the <strong>major</strong> criteria of <strong>modified Duke criteria</strong> for the diagnosis of<strong> infective endocarditis</strong>. All other options are minor criteria.</p>\n<p><strong>Infective endocarditis</strong> is associated with bacterial or fungal infection of the valvular or endocardial surface of the heart. The definitive diagnosis can only be established by histological and microbiological examinations of the vegetation.</p>\n<p>However, a diagnostic schema called, <strong>modified Duke criteria,</strong> is usually used for diagnosis. The criteria are based on clinical, laboratory, and echocardiographic findings commonly encountered in patients with endocarditis, as described below.</p>\n<p>The diagnosis is made based on the presence of</p>\n<ul>\n<li>Two major criteria, or</li>\n<li>One major and three minor criteria, or</li>\n<li>Five minor criteria.</li>\n</ul>\n</div>\n</div>\n</div>\n</div><hr><h3>Related Pearl: Modified Duke's criteria for diagnosis of infective endocarditis</h3><div class=\"page\" title=\"Page 2415\">\n<div class=\"section\">\n<div class=\"layoutArea\">\n<div class=\"column\">\n<p>Diagnosis of Infective endocarditis is by Duke's Criteria, which requires either:</p>\n</div>\n</div>\n</div>\n</div>\n<ol>\n<li>Pathologic criteria</li>\n<li>Clinical criteria</li>\n</ol>\n<p>If clinical criteria are used, definitive endocarditis is defined by the presence of&nbsp;<strong>2 major </strong>or&nbsp;<strong>1 major + 3 minor </strong>or&nbsp;<strong>5 minor criteria.</strong></p>\n<p>The presence of single pathological criteria is definitive of infective endocarditis.</p><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/186ed21749ed4d3ab7e43344abb39a78x1200x2770.JPEG\" alt=\"Pearl Image\"><p>Note:&nbsp;The diagnosis of endocarditis is rejected if an alternative diagnosis is established either when:</p>\n<ul class=\"p-rich_text_list p-rich_text_list__bullet\" data-stringify-type=\"unordered-list\" data-indent=\"0\" data-border=\"0\">\n<li data-stringify-indent=\"0\" data-stringify-border=\"0\">Symptoms resolve and do not recur with &lt;4 days of antibiotic therapy OR</li>\n<li data-stringify-indent=\"0\" data-stringify-border=\"0\">If surgery or autopsy yields no pathologic or macroscopic evidence of endocarditis in &lt;4 days of antimicrobial therapy.</li>\n</ul>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MF8596",
      "difficulty": "medium"
    },
    {
      "text": "The Rosemont criteria for the diagnosis of chronic pancreatitis is based on:",
      "choices": [
        {
          "id": 1,
          "text": "CT scan findings"
        },
        {
          "id": 2,
          "text": "ERCP findings"
        },
        {
          "id": 3,
          "text": "MRCP findings"
        },
        {
          "id": 4,
          "text": "EUS findings"
        }
      ],
      "correct_choice_id": 4,
      "solution": "<p><strong>Rosemont&rsquo;s criteria</strong> for the diagnosis of<strong> chronic pancreatitis</strong> is based on endoscopic ultrasonographic (<strong>EUS</strong>)<strong> findings.</strong></p><hr><h3>Related Pearl: Rosemont’s criteria for the diagnosis of chronic pancreatitis</h3><table>\n<tbody>\n<tr>\n<td>&nbsp;</td>\n<td>Parenchymal features</td>\n<td>Ductal features</td>\n</tr>\n<tr>\n<td>Major criteria</td>\n<td><strong>Major A criteria:</strong>\n<ul>\n<li aria-level=\"1\">Hyperechoic foci with post-acoustic shadowing</li>\n</ul>\n<strong>Major B criteria:</strong>\n<ul>\n<li aria-level=\"1\">Honeycombing lobularity</li>\n</ul>\n</td>\n<td><strong>Major A criteria:</strong>\n<ul>\n<li aria-level=\"1\">Main pancreatic duct calculi</li>\n</ul>\n</td>\n</tr>\n<tr>\n<td>Minor criteria</td>\n<td>\n<ul>\n<li>Hyperechoic, non-shadowing foci &ge;3 mm in length and width</li>\n<li>Lobularity including three or more noncontiguous lobules in the body or tail</li>\n<li>Pancreatic cysts &ge;2 mm in short axis</li>\n<li>At least three strands*</li>\n</ul>\n<p><sup>&nbsp;&nbsp; *</sup>Strands are defined as hyperechoic lines &ge;3 mm in length seen in at least two different directions in the body or tail of the pancreas.</p>\n</td>\n<td>\n<ul>\n<li>Irregular main pancreatic duct (MPD) contour</li>\n<li>Dilated side branches<sup>+</sup></li>\n<li>Main pancreatic duct dilation (&ge;3.5 mm in the body or &ge;1.5 mm in the tail)</li>\n<li>Hyperechoic MPD margin &gt;50% of the main pancreatic duct in the body and tail.</li>\n</ul>\n<br />&nbsp;<sup>+</sup>&ge;3 tubular anechoic structures, each one &ge;1 mm in width, budding from MPD</td>\n</tr>\n<tr>\n<td>&nbsp;</td>\n<td colspan=\"2\">Diagnosis of Chronic Pancreatitis:<br />\n<ul>\n<li aria-level=\"1\">Consistent with chronic pancreatitis</li>\n<ul>\n<li aria-level=\"2\">1 major A criterion + &ge;3 minor criteria</li>\n<li aria-level=\"2\">1 major A criterion + major B criterion</li>\n<li aria-level=\"2\">2 major A criteria</li>\n</ul>\n</ul>\n<ul>\n<li aria-level=\"1\">Suggestive of chronic pancreatitis (requires imaging for confirmation)</li>\n<ul>\n<li aria-level=\"2\">1 major A criterion + &lt;3 minor criteria</li>\n<li aria-level=\"2\">1 major B criterion + &ge;3 minor criteria</li>\n<li aria-level=\"2\">&ge;5 minor criteria</li>\n</ul>\n</ul>\n<ul>\n<li aria-level=\"1\">Indeterminate for chronic pancreatitis (requires imaging for confirmation)</li>\n<ul>\n<li aria-level=\"2\">3-4 minor criteria in the absence of major criteria</li>\n<li aria-level=\"2\">Major B criterion + &lt;3 minor criteria</li>\n</ul>\n</ul>\n<ul>\n<li aria-level=\"1\">&nbsp;Normal</li>\n<ul>\n<li aria-level=\"2\">&lt;3 minor criteria</li>\n</ul>\n</ul>\n</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>\n<p>&nbsp;</p>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MB7603",
      "difficulty": "medium"
    },
    {
      "text": "Which of the following is not a criteria for severe acute malnutrition?",
      "choices": [
        {
          "id": 1,
          "text": "Weight for height less than -3 SD"
        },
        {
          "id": 2,
          "text": "MUAC < 115mm"
        },
        {
          "id": 3,
          "text": "B/L Pedal Edema"
        },
        {
          "id": 4,
          "text": "Weight for age less than -3 SD"
        }
      ],
      "correct_choice_id": 4,
      "solution": "<p><strong>Severe acute malnutrition</strong> (SAM) according to the WHO criteria is the&nbsp;<strong>w</strong><strong>eight for height (not age) less than minus -3 SD.</strong></p>\n<p><strong>Severe acute malnutrition</strong> (SAM) in children of ages <strong>6 to 59 months</strong> is defined by the WHO as any of the following:</p>\n<ul>\n<li><strong>Weight-for-length</strong> (or height) <strong>below &minus;3 SD</strong> of the WHO child growth standards</li>\n<li>Presence of <strong>bipedal edema</strong></li>\n<li>Mid-upper arm circumference&nbsp;<strong>(</strong><strong>MUAC)</strong>&nbsp;<strong>&lt;11.5 cm</strong>.<strong>&nbsp;</strong></li>\n</ul>\n<p>Management of SAM is given below:&nbsp;</p><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/00d582a91da04e21a88a06688cfccbf1x720x799.JPEG\" alt=\"Explanation Image\"><hr><h3>Related Pearl: World Health Organization (WHO) classification of nutritional status of infants and children</h3><table>\n<tbody>\n<tr>\n<td>\n<div><span><strong>Nutritional status</strong></span></div>\n</td>\n<td>\n<div><span><strong>Criteria </strong>(from birth to 5 years)</span></div>\n</td>\n</tr>\n<tr>\n<td>\n<p><span>Obese</span></p>\n</td>\n<td>\n<p><span><strong>Weight-for-height</strong>/length&nbsp;&gt;3 SD</span></p>\n<p><span><strong>BMI-for-</strong>age &gt;3 SD</span></p>\n</td>\n</tr>\n<tr>\n<td><span>Overweight</span></td>\n<td>\n<p><span><strong>Weight-for-height</strong>/length&nbsp;&gt;2 SD and &le;3 SD</span></p>\n<p><span><strong>BMI-for-age</strong> &gt;2 SD and &le;3 SD</span></p>\n</td>\n</tr>\n<tr>\n<td><span>Moderately underweight</span></td>\n<td><span><strong>Weight-for-age</strong> &lt;&ndash;2 SD and &ge;&ndash;3 SD</span></td>\n</tr>\n<tr>\n<td><span>Severely underweight</span></td>\n<td><span><strong>Weight-for-age</strong> &lt;&ndash;3 SD</span></td>\n</tr>\n<tr>\n<td><span>Moderate acute malnutrition</span></td>\n<td>\n<p><span><strong>Weight-for-height</strong>/length&nbsp;&le;&ndash;2 SD and &ge;&ndash;3 SD</span></p>\n<p><span><strong>BMI-for-age</strong> &le;&ndash;2 SD and &ge;&ndash;3 SD</span></p>\n<p><span><strong>Mid-upper arm circumference</strong> &ge;115&nbsp;mm and &lt;125&nbsp;mm</span></p>\n</td>\n</tr>\n<tr>\n<td><span>Severe acute malnutrition</span></td>\n<td>\n<p><span><strong>Weight-for-height</strong>/length&nbsp;&lt;&ndash; 3 SD</span></p>\n<p><span><strong>BMI-for-age</strong> &lt;&ndash; 3 SD</span></p>\n<p><span><strong>Mid-upper arm circumference</strong> &lt;115 mm</span></p>\n<p><span>Bilateral pitting edema</span></p>\n</td>\n</tr>\n<tr>\n<td><span>Moderately stunted (or) moderate chronic malnutrition</span></td>\n<td><span><strong>Height/Length-for-age</strong> &le;&ndash;2 SD and &ge;&ndash;3 SD</span></td>\n</tr>\n<tr>\n<td><span>Severely stunted (or) severe chronic malnutrition</span></td>\n<td><span><strong>Height/Length-for-age</strong> &lt;&ndash;3 SD</span></td>\n</tr>\n<tr>\n<td><span>Moderately wasted</span></td>\n<td><span><strong>Weight-for-height</strong>/length &le;&ndash;2 SD and &ge;&ndash;3 SD</span></td>\n</tr>\n<tr>\n<td><span>Severely wasted</span></td>\n<td><span><strong>Weight-for-height</strong>/length &lt;-3 SD</span></td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>\n<p><span><strong>SD</strong> - Standard deviation (from the median)</span></p>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MD4433",
      "difficulty": "easy"
    },
    {
      "text": "A diabetic patient with foci of infection was diagnosed with systemic inflammatory response syndrome (SIRS). Which of the following is not included under the diagnostic criteria for SIRS?",
      "choices": [
        {
          "id": 1,
          "text": "Bradycardia"
        },
        {
          "id": 2,
          "text": "Tachypnea"
        },
        {
          "id": 3,
          "text": "Hypothermia"
        },
        {
          "id": 4,
          "text": ">10% band forms on peripheral smear"
        }
      ],
      "correct_choice_id": 1,
      "solution": "<p><strong>Bradycardia</strong> is not a part of SIRS criteria.&nbsp;</p>\n<p class=\"p2\">SIRS is diagnosed when <strong>two</strong> of the following are present:</p>\n<ul>\n<li class=\"p2\">Hyperthermia (temperature &gt;38&deg;C) or hypothermia (temperature &lt;36&deg;C)</li>\n<li class=\"p2\">Tachypnea (&gt;20 breaths/min) or arterial carbon dioxide tension (PaCO<sub>2</sub>) of less than 32 mm Hg</li>\n<li class=\"p2\"><strong>Tachycardia</strong> (&gt;90 beats/min)&nbsp;</li>\n<li class=\"p2\">White cell count &gt;12 x 10<sup>9</sup>/L or &lt;4 x 10<sup>9</sup>/L or &gt;10% Band forms</li>\n</ul>\n<p class=\"p2\">Sepsis is SIRS with a documented infection.</p>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MF7195",
      "difficulty": "medium"
    },
    {
      "text": "A 40-year-old man presented with nausea, vomiting, and acute onset epigastric pain radiating to the back. Investigations revealed elevated levels of serum amylase and lipase. An abdominal X-ray showed the colon-cut off sign.  Which of the following criteria uses CT to stage the severity of this condition?",
      "choices": [
        {
          "id": 1,
          "text": "Modified Glasgow score"
        },
        {
          "id": 2,
          "text": "Balthazar score"
        },
        {
          "id": 3,
          "text": "APACHE II score"
        },
        {
          "id": 4,
          "text": "Ranson criteria"
        }
      ],
      "correct_choice_id": 2,
      "solution": "<p>The clinical features and the abdominal radiograph showing the<strong> colon cut-off sign</strong> are suggestive of <strong>acute pancreatitis.</strong>&nbsp;<strong class=\"ng-binding\">Balthazar Scoring</strong><strong class=\"ng-binding\">&nbsp;</strong>is used for <strong>staging</strong> the <strong>severity</strong> of acute pancreatitis <strong>based</strong> on <strong>CT</strong>&nbsp;findings.</p>\n<p>The most<strong> common causes </strong>of acute pancreatitis are - gallstones, alcoholism, post-ERCP (endoscopic retrograde cholangiopancreatography), drugs (steroids, thiazides, azathioprine, etc.), hypercalcemia,&nbsp;etc.&nbsp;</p>\n<p>The<strong> classical presentation </strong>includes acute severe&nbsp;<strong>epigastric pain&nbsp;</strong>radiating&nbsp;to the<strong> back </strong>and<strong>&nbsp;relieved </strong>by<strong> leaning forward. </strong>Nausea and vomiting can also be present<strong>. Clinical signs</strong> such as&nbsp;hypotension, tachycardia, <strong>Grey Turner sign</strong>&nbsp;(bluish discoloration of the&nbsp;flanks), and&nbsp;<strong>Cullen&rsquo;s sign</strong> (bluish discoloration around the&nbsp;umbilicus) can be present.</p>\n<p>The Grey Turner sign is shown below:</p><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/3ecb5ce91caa456bac24e7597b68e9d9x602x316.JPEG\" alt=\"Explanation Image\"><p>Cullen's sign is shown below:</p><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/b488bfe58c294d47b2e7108f26ec94d5x561x364.JPEG\" alt=\"Explanation Image\"><p>The below abdominal x-ray shows an abrupt transition from distended to collapsed colon just beyond the splenic flexure. This is known as a <strong>colon cut-off sign</strong>.</p><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/9c33888769af41d2af4dc648830fbac6x1024x1020.JPEG\" alt=\"Explanation Image\"><div class=\"panel-heading\">\n<p><strong>Laboratory findings </strong>include <strong>elevated&nbsp;</strong><strong>serum amylase </strong>and serum<strong> lipase.</strong>&nbsp;Serum amylase levels are non-specific, while serum lipase&nbsp;is&nbsp;more specific,&nbsp;and lipase is more useful when the&nbsp;patient presents 24&ndash;48 hours&nbsp;from the onset of symptoms.</p>\n<p><strong>Management</strong> involves keeping the patient nil per oral, fluid replacement, and pain control. Antibiotics are rarely required unless the infection spreads.</p>\n</div><p>Other options-</p>\n<p>Option A:<strong> Modified Glasgow</strong> score uses 8 laboratory findings to predict the severity of acute pancreatitis (within 48 hours of treatment onset). It is not a CT-based scoring system.</p>\n<p>Option C:<strong> APACHE II score</strong> (Acute Physiology and Chronic Health Evaluation&nbsp;score) is another clinical tool that assesses the risk of mortality and predicts prolonged intensive care treatment. It is also not CT-based.</p>\n<p>Option D: <strong>Ranson's criteria&nbsp;</strong>uses 11 clinical and laboratory findings at admission and after 48 hours to assess clinical severity. It does not include CT scan findings.</p><hr><h3>Related Pearl: Computed Tomography Severity Index (CTSI)/Balthazar Scoring for Acute Pancreatitis</h3><table>\n<tbody>\n<tr>\n<td colspan=\"3\"><strong>Balthazar Score</strong></td>\n</tr>\n<tr>\n<td><strong>Balthazar Grade</strong></td>\n<td><strong>Appearance on CT</strong></td>\n<td><strong>CT Grade Points</strong></td>\n</tr>\n<tr>\n<td>Grade A</td>\n<td>Normal CT</td>\n<td>0 Points</td>\n</tr>\n<tr>\n<td>Grade B</td>\n<td>Focal or diffuse enlargement of the pancreas</td>\n<td>1 Point</td>\n</tr>\n<tr>\n<td>Grade C</td>\n<td>Pancreatic gland abnormalities and peripancreatic inflammation&nbsp;</td>\n<td>2 Points</td>\n</tr>\n<tr>\n<td>Grade D&nbsp;</td>\n<td>Fluid collection in a single location</td>\n<td>3 Points</td>\n</tr>\n<tr>\n<td>Grade E</td>\n<td>Two or more sites of fluid collection and/ or gas bubbles in, or adjacent to, the pancreas</td>\n<td>4 Points</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>\n<p>&nbsp;</p>\n<table>\n<tbody>\n<tr>\n<td colspan=\"2\"><strong>Necrosis Score</strong>&nbsp;&nbsp;</td>\n</tr>\n<tr>\n<td>Necrosis Percentage</td>\n<td>CT grade points</td>\n</tr>\n<tr>\n<td>No necrosis</td>\n<td>0 points</td>\n</tr>\n<tr>\n<td>0 to 30% necrosis</td>\n<td>2 points</td>\n</tr>\n<tr>\n<td>30 to 50% necrosis</td>\n<td>4 points</td>\n</tr>\n<tr>\n<td>Over 50% necrosis</td>\n<td>6 points</td>\n</tr>\n<tr>\n<td colspan=\"2\">\n<p>The numerical Computed Tomography Severity Index (CTSI) has a <strong>maximum of 10&nbsp;points</strong>, and<strong>&nbsp;</strong>it is the <strong>sum</strong> of the Balthazar grade points and pancreatic necrosis grade points.&nbsp;</p>\n</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>\n<p>CTSI score 0-3: Mild pancreatitis</p>\n<p>CTSI score 4-6: Moderate pancreatitis</p>\n<p>CTSI score 7-10: Severe pancreatitis</p>\n<p>&nbsp;</p><hr><h3>Related Pearl: Ranson Prognostic Criteria for Acute Pancreatitis</h3><table>\n<tbody>\n<tr>\n<td colspan=\"3\"><strong>Ranson's prognostic criteria at presentation</strong></td>\n</tr>\n<tr>\n<td><strong>Parameter</strong></td>\n<td><strong>Non-gallstone pancreatitis</strong></td>\n<td><strong>Gallstone pancreatitis</strong></td>\n</tr>\n<tr>\n<td><strong>Age</strong></td>\n<td>&gt;55 years</td>\n<td>&gt;70 years</td>\n</tr>\n<tr>\n<td><strong>Blood glucose level</strong></td>\n<td>&gt;200 mg/dL</td>\n<td>&gt;220 mg/dL</td>\n</tr>\n<tr>\n<td><strong>White blood cell count</strong></td>\n<td>&gt;16,000 cells/mm<sup>3</sup></td>\n<td>&gt;18,000 cells/mm<sup>3</sup></td>\n</tr>\n<tr>\n<td><strong>Serum LDH level</strong></td>\n<td>&gt;350 IU/L</td>\n<td>&nbsp;&gt;400 IU/L</td>\n</tr>\n<tr>\n<td><strong>Serum Aspartate aminotransferase level</strong></td>\n<td>&nbsp;&gt;250 IU/L</td>\n<td>&nbsp;&gt;250 IU/L</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>\n<p>&nbsp;</p>\n<table>\n<tbody>\n<tr>\n<td colspan=\"3\"><strong>Ranson's prognostic criteria after 48 hours of admission</strong></td>\n</tr>\n<tr>\n<td><strong>Parameter</strong></td>\n<td><strong>Non-gallstone pancreatitis</strong></td>\n<td><strong>Gallstone pancreatitis&nbsp;</strong></td>\n</tr>\n<tr>\n<td><strong>Hematocrit fall<br /></strong></td>\n<td>&gt;10%</td>\n<td>&gt;10%</td>\n</tr>\n<tr>\n<td><strong>Serum calcium level</strong></td>\n<td>&lt;8 mg/dL</td>\n<td>&lt;8 mg/dL</td>\n</tr>\n<tr>\n<td><strong>Base deficit</strong></td>\n<td>&gt;4 mEq/L</td>\n<td>&gt;5 mEq/L</td>\n</tr>\n<tr>\n<td><strong>Blood urea nitrogen level increase&nbsp;<br /></strong></td>\n<td>\n<p>&ge;5 mg/dL despite IV fluid hydration</p>\n</td>\n<td>&ge;2 mg/dL despite IV fluid hydration</td>\n</tr>\n<tr>\n<td><strong>Fluid sequestration<br /></strong></td>\n<td>&nbsp;&gt;6 L</td>\n<td>&nbsp;&gt;4 L</td>\n</tr>\n<tr>\n<td><strong>PaO<sub>2</sub></strong></td>\n<td>&nbsp;&lt;60 mm Hg</td>\n<td>&nbsp;Not available</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>\n<p>Ranson score<strong> &ge;3</strong> defines <strong>severe pancreatitis</strong>.</p>\n<p><strong>Score Interpretation</strong></p>\n<ul>\n<li class=\"half_rhythm\">\n<div>0 to 2 points: 0% to 3% mortality</div>\n</li>\n<li class=\"half_rhythm\">\n<div>3 to 4 points: 15% mortality</div>\n</li>\n<li class=\"half_rhythm\">\n<div>5 to 6 points: 40% mortality</div>\n</li>\n<li class=\"half_rhythm\">\n<div>7 to 11: nearly 100% mortality</div>\n</li>\n</ul>\n<p>&nbsp;</p><hr><h3>Related Pearl: Assessment of severity of acute pancreatitis</h3><ul>\n<li><strong>Bedside Index for Severity of Acute Pancreatitis (BISAP) </strong>includes:\n<ul>\n<li>Blood urea nitrogen, &gt; 25 mg/dL</li>\n<li>Impaired mental status, Glasgow Coma Scale (GCS) score &lt;15</li>\n<li>Systemic inflammatory response syndrome (SIRS)</li>\n<li>Age &gt; 60 years</li>\n<li>Pleural effusion<br />One point is given for each.&nbsp;BISAP score&nbsp;&ge; 3 indicates severe pancreatitis.</li>\n</ul>\n</li>\n</ul>\n<ul>\n<li><strong>Harmless Acute Pancreatitis Score (HAPS)</strong><br />If all the following are present then it is considered non-severe, i.e., no death, no need for dialysis, and no need for ventilation:\n<ul>\n<li>Absence of rebound tenderness or guarding</li>\n<li>Normal hematocrit</li>\n<li>Normal serum creatinine<br /><br /></li>\n</ul>\n</li>\n<li><strong>Acute Physiology and Chronic Health Evaluation (APACHE II</strong><strong>) </strong>\n<ul>\n<li>A score of 8 or more is considered to be severe</li>\n<li>Can be done at admission and repeated any time</li>\n<li>Complex, not specific for AP, and based on the patient&rsquo;s age</li>\n</ul>\n</li>\n</ul>\n<ul>\n<li><strong>Ranson&rsquo;s score</strong></li>\n<li><strong>Modified Glasgow criteria -&nbsp;</strong>3 or more positive criteria, the disease is considered to be&nbsp;<strong>severe</strong></li>\n<li><strong>Atlanta classification</strong></li>\n</ul>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MF0077",
      "difficulty": "medium"
    },
    {
      "text": "During your ICU posting, your senior resident advises you to extubate the patients, who are on mechanical ventilation and are found to be improving. In order to plan for weaning, the rapid shallow breathing index of the patient should be:",
      "choices": [
        {
          "id": 1,
          "text": "More than 100"
        },
        {
          "id": 2,
          "text": "Less than 100"
        },
        {
          "id": 3,
          "text": "Less than 120"
        },
        {
          "id": 4,
          "text": "More than 120"
        }
      ],
      "correct_choice_id": 2,
      "solution": "<p><span data-preserver-spaces=\"true\"><strong>Rapid</strong> <strong>shallow breathing index (RSBI)</strong> should be <strong>less than&nbsp;100.</strong></span></p>\n<p><span data-preserver-spaces=\"true\">Patients with an<strong> RSBI &lt;100</strong> are eligible candidates for <strong>successful</strong> extubation. But, those with an <strong>RSBI &gt;120</strong> will need some degree of mechanical <strong>ventilator support</strong>.</span></p>\n<p><span data-preserver-spaces=\"true\">A patient on mechanical ventilation should be tried to wean off when the <strong>patient no longer requires the ventilator</strong>. This condition usually met when the patient can</span><strong><span data-preserver-spaces=\"true\">&nbsp;breathe spontaneously</span></strong><span data-preserver-spaces=\"true\">,</span><span data-preserver-spaces=\"true\">&nbsp;is hemodynamically stable with adequate arterial oxygen saturation, and when he has a pH &gt;7.25.</span></p>\n<p><span data-preserver-spaces=\"true\">Additional <strong>criteria</strong> include,</span></p>\n<ul>\n<li><span data-preserver-spaces=\"true\">Inspiratory pressure: -20-30cm H2O</span></li>\n<li><span data-preserver-spaces=\"true\">Tidal volume: 4-6ml/kg</span></li>\n<li>Vital capacity: &gt;10 mL/kg</li>\n<li>Minute ventilation: &lt;10 L/min</li>\n<li>Rapid shallow breathing index(RSBI): &lt;100</li>\n</ul>\n<div class=\"page\" title=\"Page 2291\">\n<div class=\"layoutArea\">\n<div class=\"column\">\n<p>Patients are weaned off from the ventilator with the help of <strong>techniques</strong> such as pressure support, synchronized intermittent mandatory ventilation<strong>&nbsp;</strong>(SIMV), and periods of spontaneous breathing (either on a &Tau;-piece or on a low setting of CPAP).</p>\n</div>\n</div>\n</div><hr><h3>Related Pearl: Mechanical Criteria for Weaning or Extubation</h3><ul>\n<li>Inspiratory pressure: -20 to -30cm H2O</li>\n<li>Tidal volume: 4-6ml/kg</li>\n<li>Vital capacity: &gt;10 mL/kg</li>\n<li>Minute ventilation: 10L/min</li>\n<li>Rapid shallow breathing index: &lt;100</li>\n</ul>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MD7349",
      "difficulty": "medium"
    },
    {
      "text": "Which of the following options is incorrect regarding ROME IV criteria?",
      "choices": [
        {
          "id": 1,
          "text": "Recurrent abdominal pain, on average should be present for at least 1 day per week in the last 3 months"
        },
        {
          "id": 2,
          "text": "Associated with a change in stool form"
        },
        {
          "id": 3,
          "text": "Associated with a change in stool frequency"
        },
        {
          "id": 4,
          "text": "Abdominal pain for the last 3 weeks with symptom onset at least 6 months before diagnosis."
        }
      ],
      "correct_choice_id": 4,
      "solution": "<p>The <strong class=\"ng-binding\">ROME IV Diagnostic criteria for IBS </strong> must be fulfilled for the last <strong>3 months</strong> with symptom <strong>onset</strong> at least <strong>6 months</strong> before diagnosis.</p>\n<p>The <strong>onset</strong> of symptoms during a period of <strong>stress </strong>or emotional upset is a feature that supports a diagnosis of irritable bowel syndrome (IBS).</p>\n<p>Based on bowel movement patterns, IBS is classified as:</p>\n<ul>\n<li><strong>IBS-C</strong>: Irritable bowel syndrome-constipation predominant</li>\n<li><strong>IBS-D</strong>: Irritable bowel syndrome-diarrhea predominant</li>\n<li><strong>IBS-M</strong>: Irritable bowel syndrome-mixed</li>\n</ul>\n<p>Alteration in bowel habits (constipation/diarrhea) is the most consistent clinical feature in IBS. This means that a majority of people suffering from IBS have an alteration in bowel habits. The most common pattern is constipation alternating with diarrhea, usually with one of these symptoms predominating.</p>\n<p>IBS is a <strong>clinical diagnosis</strong> that can be made without performing many tests if the patient presents with typical symptoms. However, it is recommended to perform the following tests in most patients to <strong>rule out</strong> other conditions:</p>\n<ul>\n<li>Complete blood count</li>\n<li>Sigmoidoscopic examination</li>\n<li>Stool examination for ova and parasites</li>\n<li>3-week lactose-free diet</li>\n<li>Fecal calprotectin levels help distinguish inflammatory bowel disease (IBD) from IBS</li>\n</ul>\n<p>In patients <strong>&gt;40 years</strong>, air-contrast <strong>barium enema</strong> or <strong>colonoscopy</strong> should also be performed.</p><hr><h3>Related Pearl: ROME IV Diagnostic criteria for IBS</h3><p class=\"bulletIndent1\">According to the Rome IV criteria, IBS is defined as recurrent <strong>abdominal pain </strong>for&nbsp;at least <strong>1 day per week</strong> in the last <strong>3 months</strong>. It must be associated with <strong>2 or more</strong> of the following criteria:</p>\n<ul>\n<li class=\"bulletIndent2\">Related to defecation&nbsp;(improvement or worsening)</li>\n<li class=\"bulletIndent2\">Associated with a change in stool frequency</li>\n<li class=\"bulletIndent2\">Associated with a change in stool form (appearance)</li>\n</ul>\n<p>The above criteria must be fulfilled for <strong>3 months</strong> with&nbsp;<strong>onset</strong>&nbsp;of some symptoms at least <strong>6 months</strong> before diagnosis.</p><hr><h3>Related Pearl: Drugs used in irritable bowel syndrome (IBS)</h3><p>For abdominal pain</p>\n<ul>\n<li>Antispasmodics - Dicyclomine</li>\n<li>Tricyclic antidepressants - Amitriptyline, Imipramine</li>\n<li>Selective serotonin reuptake inhibitor - Citalopram</li>\n</ul>\n<p>For diarrhoea</p>\n<ul>\n<li>Opiate - Loperamide</li>\n<li>5-HT3 antagonist - Alosetron</li>\n<li>Bile acid sequestrant - Cholestyramine resin</li>\n</ul>\n<p>For constipation</p>\n<ul>\n<li>Laxatives such as psyllium/ispaghula husk and polyethylene glycol</li>\n<li>Cl<sup>-</sup> channel activator - Lubiprostone</li>\n<li>Guanylate cyclase agonist - Linaclotide</li>\n<li>5-HT4 agonist - Tegaserod</li>\n<li>Selective serotonin reuptake inhibitor - Paroxetine</li>\n</ul>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MD7212",
      "difficulty": "medium"
    },
    {
      "text": "According to NADA's criteria, which of these findings would not be sufficient to consider the diagnosis of congenital heart disease in an infant?",
      "choices": [
        {
          "id": 1,
          "text": "Presence of abnormal ECG alone"
        },
        {
          "id": 2,
          "text": "Presence of cyanosis alone"
        },
        {
          "id": 3,
          "text": "Presence of abnormal S2 and abnormal chest -X-ray"
        },
        {
          "id": 4,
          "text": "Presence of grade 3 systolic murmur alone"
        }
      ],
      "correct_choice_id": 1,
      "solution": "<p>According to <strong>NADA's criteria</strong>, the presence&nbsp;of <strong>abnormal ECG alone</strong> is <strong>not sufficient</strong> by itself to indicate congenital heart disease in an infant as it is a <strong>minor criteria</strong>.&nbsp;NADA&rsquo;s criteria is used to diagnose<strong> congenital heart disease</strong> in children. The presence of <strong>1 major or 2 minor criteria</strong> indicates congenital heart disease.</p>\n<table>\n<tbody>\n<tr>\n<td><strong>Major criteria&nbsp;</strong></td>\n<td><strong>Minor criteria</strong></td>\n</tr>\n<tr>\n<td>Systolic murmur grade 3 or more</td>\n<td>Systolic murmur &lt; grade 3</td>\n</tr>\n<tr>\n<td>Any diastolic murmur</td>\n<td>Abnormal second sound (S2)</td>\n</tr>\n<tr>\n<td>Cyanosis</td>\n<td>Abnormal ECG</td>\n</tr>\n<tr>\n<td>Congestive cardiac failure</td>\n<td>\n<p>Abnormal chest X-ray findings</p>\n</td>\n</tr>\n<tr>\n<td>&nbsp;</td>\n<td>\n<p>Abnormal BP</p>\n</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>\n<p>&nbsp;</p>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MF8619",
      "difficulty": "medium"
    },
    {
      "text": "A 5-year-old child with Wilson's disease is being considered for liver transplantation. Which of the following is not a parameter in the selection criteria for transplantation?",
      "choices": [
        {
          "id": 1,
          "text": "Age <10years"
        },
        {
          "id": 2,
          "text": "PT >100 s"
        },
        {
          "id": 3,
          "text": "Bilirubin >300 μmol/L"
        },
        {
          "id": 4,
          "text": "Jaundice less than 7 days before development of encephalopathy"
        }
      ],
      "correct_choice_id": 4,
      "solution": "<p>A 5-year-old child with Wilson's disease is a case of <strong>non-paracetamol-induced acute liver failure</strong> and jaundice&nbsp;for <strong>more than 7 days</strong> before the development of encephalopathy is one of the parameters in the&nbsp;<strong>King's College criteria for liver transplantation.</strong></p>\n<p>It includes the following parameters:</p>\n<p><strong>Non-paracetamol-induced acute liver failure</strong>:</p>\n<div class=\"page\" title=\"Page 1177\">\n<div class=\"section\">\n<div class=\"layoutArea\">\n<div class=\"column\">\n<ul>\n<li>PT &gt;100 s (INR &gt;6.5)</li>\n</ul>\n<p>&nbsp; &nbsp; &nbsp; &nbsp; or/and</p>\n<ul>\n<li><strong>Any three</strong> of the following:\n<ul>\n<li>Age &lt;10 years or &gt;40 years</li>\n<li>Etiology non-A, non-B hepatitis, or idiosyncratic drug reaction</li>\n<li><strong>Jaundice more than 7 days before the development of encephalopathy</strong> i.e., not hyperacute</li>\n<li>PT &gt;50 s (INR &gt; 3.5)</li>\n<li>Bilirubin &gt; 18 mg/dl (300 &mu;mol/L)</li>\n</ul>\n</li>\n</ul>\n<p><strong>Paracetamol-induced acute liver failure:</strong></p>\n<div class=\"page\" title=\"Page 1177\">\n<div class=\"section\">\n<div class=\"layoutArea\">\n<div class=\"column\">\n<ul>\n<li>pH &lt;7.30 (irrespective of the grade of encephalopathy)&nbsp;</li>\n</ul>\n<p>&nbsp; &nbsp; &nbsp; &nbsp; or/and</p>\n<ul>\n<li><strong>All three</strong> of the following:\n<ul>\n<li>Prothrombin time &gt;100 s (INR &gt;6.5)</li>\n<li>Serum creatinine &gt;3.4 mg/dl (300 &mu;mol/L)</li>\n<li>Grade 3 or 4 hepatic encephalopathy</li>\n</ul>\n</li>\n</ul>\n</div>\n</div>\n</div>\n</div>\n</div>\n</div>\n</div>\n</div>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MD0848",
      "difficulty": "medium"
    },
    {
      "text": "A patient who is a known case of cirrhosis presents with lethargy and disorientation to time. On examination, flapping tremors are noted. What is the most likely grading of hepatic encephalopathy in this patient according to West Haven criteria?",
      "choices": [
        {
          "id": 1,
          "text": "Grade 4"
        },
        {
          "id": 2,
          "text": "Grade 3"
        },
        {
          "id": 3,
          "text": "Grade 2"
        },
        {
          "id": 4,
          "text": "Grade 1"
        }
      ],
      "correct_choice_id": 3,
      "solution": "<p><strong>Disorientation to time</strong>, and <strong>lethargy</strong>, in a known case of cirrhosis, suggest <strong>grade 2&nbsp;</strong>hepatic encephalopathy according to <strong>West Haven criteria</strong>.</p>\n<p><strong>Hepatic encephalopathy</strong> is the alteration of mental status and cognitive function occurring in liver failure. This occurs due to the<strong> failure of removal</strong> of gut-derived neurotoxins like <strong>ammonia by liver.</strong> These neurotoxins enter the brain leading to the development of symptoms.</p>\n<div class=\"page\" title=\"Page 2459\">\n<div class=\"section\">\n<div class=\"layoutArea\">\n<div class=\"column\">\n<p>In patients with cirrhosis, encephalopathy is often found as a result of certain precipitating events such as hypokalemia, infection, an increased dietary protein load, or electrolyte disturbances.</p>\n<p><strong>Treatment of hepatic encephalopathy</strong>&nbsp;includes:</p>\n<ul>\n<li>Correction of precipitating factors</li>\n<li><strong>Lactulose</strong>&nbsp;- Lactulose is a laxative that acts by getting converted to short chain fatty acid in the colon. These fatty acids result in decrease in pH of intestinal juice. At this low pH, ammonia becomes ionized and thus cannot be absorbed.</li>\n<li><strong>Rifaximin</strong>&nbsp;- It is a<strong>&nbsp;</strong>synthetic<strong>&nbsp;</strong>rifamycin that is&nbsp;poorly absorbed from the GIT&nbsp;and is indicated in the management of hepatic encephalopathy as it lowers the blood ammonia levels</li>\n<li><strong>Zinc&nbsp;</strong>- It serves as a co-factor for the urea cycle and thus stimulates it and lowers ammonia levels.</li>\n</ul>\n</div>\n</div>\n</div>\n</div><hr><h3>Related Pearl: Grading of hepatic encephalopathy - West Haven Criteria</h3><p>&nbsp;</p>\n<table>\n<tbody>\n<tr>\n<td><strong>Clinical grade</strong></td>\n<td><strong>Clinical signs</strong></td>\n<td><strong>Category</strong></td>\n</tr>\n<tr>\n<td><strong>Minimal&nbsp;</strong></td>\n<td>\n<p>Abnormal psychometric or neurophysiological tests</p>\n<p>No clinical manifestations</p>\n</td>\n<td>\n<p>Covert HE</p>\n</td>\n</tr>\n<tr>\n<td><strong>Grade 1</strong></td>\n<td>\n<p>Altered sleep pattern</p>\n<p>Changes in behavior</p>\n<p>Slurred speech</p>\n<p>Mild confusion</p>\n</td>\n<td>\n<p>Covert HE</p>\n</td>\n</tr>\n<tr>\n<td><strong>Grade 2</strong></td>\n<td>\n<p>Disoriented</p>\n<p>Lethargic</p>\n<p>Inappropriate behavior</p>\n<p>Asterixis</p>\n</td>\n<td>\n<p>&nbsp;Overt HE</p>\n</td>\n</tr>\n<tr>\n<td><strong>Grade 3</strong></td>\n<td>\n<p>Stuporous</p>\n<p>Responds to pain and voice</p>\n<p>Gross disorientation</p>\n</td>\n<td>Overt HE</td>\n</tr>\n<tr>\n<td><strong>Grade 4</strong>&nbsp;</td>\n<td>\n<p>Unresponsive to voice or pain</p>\n<p>Comatose</p>\n</td>\n<td>\n<p>Overt HE</p>\n</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MF8603",
      "difficulty": "hard"
    },
    {
      "text": "As per the Milan criteria for liver transplantation in patients with cirrhosis and hepatocellular carcinoma, which of the following would disqualify a patient for liver transplantation?",
      "choices": [
        {
          "id": 1,
          "text": "Presence of a single tumor with diameter 4.2 cm"
        },
        {
          "id": 2,
          "text": "Presence of three tumors with diameters 2.5 cm, 2.2 cm, and 1.5 cm"
        },
        {
          "id": 3,
          "text": "Presence of macrovascular invasion"
        },
        {
          "id": 4,
          "text": "Presence of two tumors with diameter 2.2 cm and 1.5 cm"
        }
      ],
      "correct_choice_id": 3,
      "solution": "<p>The presence of <strong>major vessel involvement&nbsp;</strong>would <strong>disqualify a patient for liver transplantation</strong>, as per the <strong>Milan criteria.</strong></p>\n<p>The Milan criteria are used to assess the suitability of patients with cirrhosis and hepatocellular carcinoma for liver transplantation. In order to be suitable for liver transplantation, the patient should have</p>\n<ul>\n<li>a single tumor with a diameter of &le;5 cm</li>\n<li>up to 3 tumors, each with a diameter &le;3 cm</li>\n<li>no extra-hepatic involvement</li>\n<li>no macrovascular invasion</li>\n</ul>\n<p>&nbsp;</p>\n<p>&nbsp;</p>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MF5574",
      "difficulty": "medium"
    },
    {
      "text": "Which of the following is not a part of WHO's major criteria for the diagnosis of polycythemia vera?",
      "choices": [
        {
          "id": 1,
          "text": "Subnormal serum erythropoietin level"
        },
        {
          "id": 2,
          "text": "Hematocrit >49% in men"
        },
        {
          "id": 3,
          "text": "Presence of JAK2 mutation"
        },
        {
          "id": 4,
          "text": "Bone marrow biopsy showing hypercellularity with panmyelosis"
        }
      ],
      "correct_choice_id": 1,
      "solution": "<p class=\"p1\">Subnormal serum erythropoietin level is<strong>&nbsp;a minor criterion&nbsp;</strong>for the diagnosis of polycythemia vera. The other three options are included as major criteria for the diagnosis of polycythemia vera.</p>\n<p class=\"p1\"><strong>Polycythemia vera (PCV)</strong>&nbsp;is a <strong>hematopoietic stem cell disorder</strong> in which there is an accumulation of phenotypically normal red cells, granulocytes, and platelets in the absence of a recognizable physiologic stimulus. It is the&nbsp;most common&nbsp;myeloproliferative neoplasm. The increase in the red cells is predominantly responsible for the clinical symptoms in this condition.</p>\n<p>In 15% to 20% of patients after an average period of 10 years, there is increased myelofibrosis and extensive extramedullary hematopoiesis. PCV transforms into AML in 2% of patients.</p>\n<p>The&nbsp;<strong>most common</strong>&nbsp;cytogenetic abnormality in polycythemia vera is the&nbsp;<strong><em>JAK2</em> mutation</strong>.&nbsp;</p>\n<p>Clinical features of PCV:</p>\n<ul>\n<li><strong>Splenomegaly</strong></li>\n<li><strong>Thrombocytosis&nbsp;</strong>- leads to venous arterial thrombosis, hepatic venous thrombosis. Erythromelalgia is the erythema, burning, and pain in the extremities. It also occurs due to thrombocytosis.</li>\n<li><strong>Erythrocytosis&nbsp;</strong>- leads to hyperviscosity, leading to neurologic symptoms such as vertigo, tinnitus, headache, visual disturbances,&nbsp;transient ischemic attacks (TIA), and systolic hypertension.&nbsp;</li>\n<li><strong>Aquagenic pruritis</strong></li>\n<li><strong>Hyperuricemia and gout&nbsp;</strong>- It may occur due to the large turnover of the hematopoietic stem cells</li>\n</ul>\n<p>Diagnosis: Criteria for diagnosis is given below:</p>\n<p>Major criteria:</p>\n<ol>\n<li><strong>Hb</strong>&nbsp;more than&nbsp;<strong>16.5g/dL</strong>&nbsp;in males and&nbsp;<strong>16g/dL</strong>&nbsp;in females or hematocrit of&nbsp;<strong>&gt;49%</strong>&nbsp;in men and &gt;<strong>48%</strong>&nbsp;in women</li>\n<li>Bone marrow biopsy&nbsp;showing&nbsp;<strong>hypercellularity</strong>&nbsp;with&nbsp;<strong>trilineage growth</strong>&nbsp;(panmyelosis) including prominent erythroid, granulocytic, and megakaryocytic proliferation.</li>\n<li>Presence of<strong>&nbsp;<em>JAK-2</em></strong>&nbsp;mutation</li>\n</ol>\n<p>Minor criteria:</p>\n<ul>\n<li><strong>Subnormal</strong>&nbsp;erythropoietin levels.</li>\n</ul>\n<p>Diagnosis requires all&nbsp;<strong>three major criteria</strong>&nbsp;or the first&nbsp;<strong>2 major and 1 minor criterion.</strong></p>\n<p>Management:</p>\n<ul>\n<li>Target Hb levels are <strong>&lt; 14g/dL in males and &lt; 12g/dL in females.</strong></li>\n<li>Periodic <strong>phlebotomy</strong> can be done to reduce hyperviscosity and to maintain the red cell mass. It is usually done at 3-month intervals.</li>\n<li>Anticoagulants are given when there is thrombosis.</li>\n<li>Allopurinol can be given to control hyperuricemia.</li>\n<li><strong>Ruxolitinib which is a nonspecific JAK2 inhibitor</strong>, pegylated IFN-&alpha;, or PUVA therapy can be used for intractable pruritis.</li>\n<li>Ruxolitinib or&nbsp;pegylated IFN-&alpha; can be used to manage symptomatic splenomegaly.</li>\n<li><strong>Anagrelide</strong> which is a phosphodiesterase inhibitor is used to reduce platelet count in these patients.</li>\n</ul><hr><h3>Related Pearl: WHO Polycythemia Vera Criteria</h3><p><span><strong>Major criteria:</strong></span></p>\n<p>1. Hemoglobin <strong>&gt;16.5 g/dL</strong> in men</p>\n<p>&nbsp; &nbsp; &nbsp;Hemoglobin <strong>&gt;16.0 g/dL</strong> in women&nbsp;</p>\n<p>Or</p>\n<p>&nbsp; &nbsp; &nbsp;Hematocrit <strong>&gt;49%</strong> in men</p>\n<p>&nbsp; &nbsp; &nbsp;Hematocrit <strong>&gt;48%</strong> in women&nbsp;</p>\n<p>2. Bone marrow biopsy showing <strong>hypercellularity</strong> with <strong>trilineage hyperplasia</strong>&nbsp;(panmyelosis) and prominent erythroid, granulocytic, and megakaryocytic proliferation with pleomorphic mature megakaryocytes in the bone marrow, and&nbsp;</p>\n<p>3. Presence of&nbsp;<strong>JAK2 exon 12</strong> mutation</p>\n<p><span><strong>Minor criterion:</strong></span></p>\n<p>Subnormal serum erythropoietin level</p>\n<p>Diagnosis of polycythemia vera requires meeting either all 3 major criteria&nbsp;or the first 2 major criteria along with the minor criterion</p><hr><h3>Related Pearl: Pathophysiologic Classification of Polycythemia</h3><p><strong>Pathophysiological classification of polycythemia</strong></p>\n<table>\n<tbody>\n<tr>\n<td><strong>Relative</strong></td>\n</tr>\n<tr>\n<td>Reduced plasma volume (hemoconcentration)</td>\n</tr>\n<tr>\n<td><strong>Absolute</strong></td>\n</tr>\n<tr>\n<td><strong>Primary</strong> (Low Erythropoietin)</td>\n</tr>\n<tr>\n<td>Polycythemia vera<br />Inherited erythropoietin receptor mutations (rare)</td>\n</tr>\n<tr>\n<td><strong>Secondary</strong> (High Erythropoietin)</td>\n</tr>\n<tr>\n<td>Compensatory<br />\n<ul>\n<li>Lung disease</li>\n<li>High-altitude living</li>\n<li>Cyanotic heart disease</li>\n</ul>\nParaneoplastic<br />\n<ul>\n<li>Erythropoietin-secreting tumors (e.g., renal cell carcinoma, hepatocellular carcinoma, cerebellar hemangioblastoma)</li>\n</ul>\n<p>Hemoglobin mutants with high O<sub>2</sub> affinity</p>\n<p>Inherited defects that stabilize HIF-1&alpha;</p>\n<ul>\n<li>Chuvash polycythemia (homozygous VHL mutations)</li>\n<li>Prolyl hydroxylase mutations</li>\n</ul>\n</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div><hr><h3>Related Pearl: Comparison between Properties of Various Types of Polycythemia</h3><table>\n<tbody>\n<tr>\n<td>&nbsp;</td>\n<td>Plasma volume</td>\n<td>RBC Mass</td>\n<td>O<sub>2&nbsp;</sub>saturation</td>\n<td>EPO concentration</td>\n</tr>\n<tr>\n<td>\n<p>Relative</p>\n<p>polycythemia</p>\n</td>\n<td><strong>&nbsp; &nbsp; &darr;</strong></td>\n<td><strong>N</strong></td>\n<td><strong>N</strong></td>\n<td><strong>N</strong></td>\n</tr>\n<tr>\n<td>\n<p>Polycythemia</p>\n<p>vera</p>\n</td>\n<td><strong>&nbsp; &nbsp; &uarr;</strong></td>\n<td><strong> &uarr;</strong></td>\n<td><strong>N</strong></td>\n<td><strong>&nbsp; &darr;</strong></td>\n</tr>\n<tr>\n<td>\n<p>EPO- producing tumors</p>\n</td>\n<td><strong>N</strong></td>\n<td><strong> &uarr;</strong></td>\n<td><strong>N</strong></td>\n<td><strong> &uarr;</strong></td>\n</tr>\n<tr>\n<td>\n<p>Hypoxia</p>\n<p>(High altitude)</p>\n</td>\n<td><strong>N</strong></td>\n<td><strong> &uarr;</strong></td>\n<td><strong>&nbsp; &darr;</strong></td>\n<td><strong> &uarr;</strong></td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>\n<p>EPO: Erythropoietin</p>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MF1228",
      "difficulty": "medium"
    },
    {
      "text": "The ACR-EULAR classification criteria is used in the classification of ____",
      "choices": [
        {
          "id": 1,
          "text": "Gout"
        },
        {
          "id": 2,
          "text": "Osteoarthritis"
        },
        {
          "id": 3,
          "text": "Rheumatoid arthritis"
        },
        {
          "id": 4,
          "text": "Psoriasis"
        }
      ],
      "correct_choice_id": 3,
      "solution": "<p>The <strong>ACR-EULAR</strong> classification <strong>criteria</strong> are used in the classification of <strong>rheumatoid arthritis.</strong></p>\n<p>&nbsp;A score of <strong>&ge;6</strong> fulfills the requirements for <strong>definite RA</strong>.</p><hr><h3>Related Pearl: Classification Criteria for Rheumatoid Arthritis - ACR/EULAR (2010)</h3><table>\n<tbody>\n<tr>\n<td>Criteria</td>\n<td> </td>\n<td>\n<p>Score</p>\n</td>\n</tr>\n<tr>\n<td>Joint involvement</td>\n<td>\n<p> </p>\n<p>1 large joint(shoulder,elbow,hip,knee)</p>\n<p>2-10 large joints</p>\n<p>1-3 small joints(MCP,PIP,IP,MTP,wrist)</p>\n<p>4-10 small joints</p>\n<p>&gt;10 joints(atleast 1 small joint)</p>\n</td>\n<td>\n<p> </p>\n<p> </p>\n<p>0</p>\n<p>1</p>\n<p>2</p>\n<p>3</p>\n<p>5</p>\n<p> </p>\n</td>\n</tr>\n<tr>\n<td>Serology</td>\n<td>\n<p>-ve RF and -ve ACPA</p>\n<p>Low +ve RF or anti-CCP (&lt;3 times ULN)</p>\n<p>High +ve RF or anti-CCP (&gt;3 times ULN)</p>\n</td>\n<td>\n<p>0</p>\n<p>2</p>\n<p>3</p>\n</td>\n</tr>\n<tr>\n<td>Acute phase reactants</td>\n<td>\n<p>Normal CRP and ESR</p>\n<p>Abnormal CRP or ESR</p>\n</td>\n<td>\n<p>0</p>\n<p>1</p>\n</td>\n</tr>\n<tr>\n<td>Duration of symptoms</td>\n<td>\n<p>&lt;6 weeks</p>\n<p>&gt;=6 weeks</p>\n</td>\n<td>\n<p>0</p>\n<p>1</p>\n</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>\n<div class=\"page\" title=\"Page 2898\">\n<div class=\"section\">\n<div class=\"layoutArea\">\n<div class=\"column\">\n<p>Maximum score is 10. A score of ≥6 fulfills requirements for definite RA.</p>\n<p>Abbreviations:</p>\n<ul>\n<li>ACPA, anti-citrullinated peptide antibodies;</li>\n<li>CCP, cyclic citrullinated pep- tides;</li>\n<li>IP, interphalangeal joint;</li>\n<li>MCP, metacarpophalangeal joint;</li>\n<li>MTP, metatarsophalangeal joint;</li>\n<li>PIP, proximal interphalangeal joint;</li>\n<li>RF, rheumatoid factor;</li>\n<li>ULN, upper limit of normal.</li>\n</ul>\n</div>\n</div>\n</div>\n</div>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MA7880",
      "difficulty": "medium"
    },
    {
      "text": "A  male patient presented with a fracture of the shaft of the femur following a road traffic accident. After 2 days he developed dyspnea, petechiae involving the whole body, and a fall in oxygen saturation. Fat embolism is suspected. Based on which criteria would he be diagnosed?",
      "choices": [
        {
          "id": 1,
          "text": "Gurd's criteria"
        },
        {
          "id": 2,
          "text": "Garden's criteria"
        },
        {
          "id": 3,
          "text": "Modified Wells criteria"
        },
        {
          "id": 4,
          "text": "CURB-65 criteria"
        }
      ],
      "correct_choice_id": 1,
      "solution": "<p><strong>Fat embolism syndrome</strong> is diagnosed based on <strong>Gurd's criteria.</strong></p>\n<p>Fat embolism is caused by the fat globules originating from the <strong>bone marrow</strong>&nbsp;following<strong> the fracture </strong>of <strong>long bones.</strong>&nbsp;Clinical features of fat embolism are usually seen <strong>within 72 hours</strong>. They include&nbsp;<strong>tachycardia, fever, breathlessness</strong>, <strong>petechiae,</strong><strong>&nbsp;confusion,</strong> and<strong> restlessness.</strong></p>\n<p>There is no specific test for diagnosis. However, <strong>sputum</strong> and&nbsp;<strong>urine analysis</strong> to look for fat globules and monitoring of blood pO2 are done. Management of fat embolism is mostly supportive, with <strong>oxygen therapy</strong>.&nbsp;</p>\n<p>Other options:</p>\n<p>Option B:&nbsp;<strong>Garden classification </strong>is used for <strong>fracture neck</strong> of the <strong>femur</strong>.<strong>&nbsp;</strong>It is based on the degree of displacement of the fracture.</p>\n<p>Option C:<strong> Modified Wells Criteria</strong> is used to predict the likelihood of <strong>pulmonary embolism.</strong></p>\n<p>Option D: <strong>CURB-65 scoring</strong> is used to assess the<strong>&nbsp;severity </strong>of<strong>&nbsp;</strong>illness in a case of pneumonia, especially<strong>&nbsp;community-acquired pneumonia.</strong></p><hr><h3>Related Pearl: Gurd's criteria for diagnosing fat embolism syndrome</h3><div class=\"ng-scope\"><strong>Major criteria</strong></div>\n<div class=\"ng-scope\">\n<ul>\n<li>Petechial rash</li>\n<li>Respiratory symptoms with radiographic changes</li>\n<li>CNS depression.</li>\n</ul>\n</div>\n<div class=\"ng-scope\">\n<div class=\"ng-scope\">\n<p class=\"ng-binding\"><strong>Minor criteria</strong></p>\n<ul>\n<li>Tachycardia</li>\n<li>Pyrexia</li>\n<li>Retinal changes (fat or petechiae)</li>\n<li>Renal abnormalities (oliguria, anuria, or lipiduria)</li>\n<li>Acute thrombocytopenia</li>\n<li>Acute decrease in hemoglobin</li>\n<li>Fat globules in sputum</li>\n<li>Increased ESR</li>\n</ul>\n<p><strong>2 major criteria</strong> OR <strong>one major criteria</strong> + <strong>four minor criteria</strong> suggest a diagnosis of fat embolism syndrome.</p>\n</div>\n</div>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MF8599",
      "difficulty": "medium"
    },
    {
      "text": "WHO criteria for blindness is visual acuity less than",
      "choices": [
        {
          "id": 1,
          "text": "1/60"
        },
        {
          "id": 2,
          "text": "6/60"
        },
        {
          "id": 3,
          "text": "3/60"
        },
        {
          "id": 4,
          "text": "6/18"
        }
      ],
      "correct_choice_id": 3,
      "solution": "<p>According to the<strong> WHO</strong>,<strong> blindness</strong> is <strong>defined</strong> as presenting <strong>visual acuity of less than 3/60</strong>, or a corresponding <strong>visual field loss to less than 10° </strong>in the <strong>better eye.</strong></p>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MC2060",
      "difficulty": "easy"
    },
    {
      "text": "UK refinement of Hanifin and Rajka criteria is used in the diagnosis of which of the following disorders?",
      "choices": [
        {
          "id": 1,
          "text": "Atopic dermatitis"
        },
        {
          "id": 2,
          "text": "Nummular eczema"
        },
        {
          "id": 3,
          "text": "Eczema herpeticum"
        },
        {
          "id": 4,
          "text": "Contact dermatitis"
        }
      ],
      "correct_choice_id": 1,
      "solution": "<p><strong>UK refinement of Hanifin and Rajka criteria</strong> is used in the diagnosis of <strong>atopic dermatitis</strong>.</p>\n<p>The <strong>original Hanifin and Rajka criteria</strong> require that patients have at least 3 of the 4 major criteria and 3 of the 23 minor criteria. Consequently, <strong>Williams et al.</strong> coordinated a <strong>UK working party</strong> to attempt to refine the criteria of Hanifin and Rajka into a repeatable and validated set of diagnostic criteria for atopic eczema.</p><hr><h3>Related Pearl: UK refinement of Hanifin & Rajka’s diagnostic criteria of atopic dermatitis (eczema)</h3><p>In order to qualify as a case of <strong>atopic dermatitis</strong> (<strong>eczema</strong>) with the <strong>UK&nbsp; diagnostic criteria</strong>, the child <strong>must have</strong>&nbsp;<strong>an itchy skin condition</strong> (or parental report of scratching or rubbing in a child).</p>\n<p><strong>Plus three or more of the following:</strong></p>\n<ul>\n<li>Onset below age of 2 years (not used if child is under 4 years)</li>\n<li>History of skin crease involvement (including cheeks in children under 10 years)</li>\n<li>History of a generally dry skin</li>\n<li>Personal history of other atopic disease (or history of any atopic disease in a first-degree relative in children under 4 years)</li>\n<li>Visible flexural dermatitis (or dermatitis of cheeks/forehead and outer limbs in children under 4 years)</li>\n</ul>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MB3839",
      "difficulty": "easy"
    },
    {
      "text": "Which of the following is not a part of the obstetric criteria for diagnosis of antiphospholipid antibody syndrome?",
      "choices": [
        {
          "id": 1,
          "text": "≥ 1 unexplained deaths of a morphologically normal fetus ≥10 weeks"
        },
        {
          "id": 2,
          "text": "Severe preeclampsia or placental insufficiency requiring delivery <37 weeks"
        },
        {
          "id": 3,
          "text": "Severe preeclampsia or placental insufficiency requiring delivery <34 weeks"
        },
        {
          "id": 4,
          "text": "≥ 3 unexplained consecutive spontaneous abortions <10 weeks"
        }
      ],
      "correct_choice_id": 2,
      "solution": "<p>Severe preeclampsia or placental insufficiency requiring delivery before 34 weeks(not &lt;37 weeks) is an obstetric criterion for diagnosis of antiphospholipid antibody (APLA) syndrome. </p>\n<p><strong>Antiphospholipid antibody syndrome</strong> is an autoimmune disorder that is commonly associated with <strong>fetal death, preterm delivery</strong>, early-onset <strong>preeclampsia</strong>, and fetal growth restriction due to placental insufficiency and thromboses. Pregnancy loss usually occurs <strong>before ten weeks</strong>.</p>\n<p>Diagnosis of APLA requires <strong>at least one clinical</strong> criterion and <strong>one laboratory</strong> criterion:</p>\n<ul>\n<li><strong>Clinical</strong>\n<ul>\n<li><strong>Obstetric criteria</strong> - \n<ul>\n<li><strong>One or more unexplained deaths</strong> of a morphologically normal fetus <strong>at or beyond ten weeks</strong>, or</li>\n<li><strong>Severe preeclampsia</strong> or placental insufficiency requiring delivery <strong>before 34 weeks</strong> or</li>\n<li><strong>Three</strong> or <strong>more </strong>unexplained <strong>consecutive spontaneous abortions before ten weeks</strong></li>\n</ul>\n</li>\n<li><strong>Vascular</strong> - One or more episodes of arterial-venous or small vessel thrombosis in any organ or tissue</li>\n</ul>\n</li>\n<li>Laboratory criteria(2 positive tests at least 12 weeks apart) - \n<ul>\n<li>Presence of lupus anticoagulant, or</li>\n<li><strong>Anticardiolipin antibodies</strong>, or</li>\n<li>Anti-β2 glycoprotein antibody</li>\n</ul>\n</li>\n</ul>\n<div class=\"page\" title=\"Page 1131\">\n<div class=\"section\">\n<div class=\"layoutArea\">\n<div class=\"column\">\n<p><strong>Specific therapy</strong> in pregnancy: <strong>Aspirin</strong> plus <strong>heparin</strong> therapy is the most effective regimen. Women are treated with low-dose aspirin and heparin for up to <strong>34 weeks</strong>. Unfractionated heparin and low molecular weight heparin (LMWH) are equally effective and safe. <strong>Corticosteroids</strong> are used only in <strong>secondary</strong> <strong>APLA</strong> syndrome (associated with SLE) and not in primary APLA syndrome. </p>\n</div>\n</div>\n</div>\n</div>\n<div class=\"page\" title=\"Page 1158\">\n<div class=\"layoutArea\">\n<div class=\"column\">\n<p>Prophylaxis:</p>\n<ul>\n<li>Women with <strong>prior thromboembolic events - </strong>prophylactic anticoagulation <strong>throughout pregnancy</strong> and <strong>six weeks postpartum</strong> with either <strong>heparin</strong> are recommended. <strong>Serial sonographic assessment</strong> of fetal growth and antepartum testing should be done in the <strong>third trimester</strong> due to the risk of fetal growth abnormalities and stillbirths.</li>\n<li>For women <strong>without prior thromboembolic events</strong>, acceptable regimes include - \n<ul>\n<li>Close antepartum maternal observation with or without prophylactic heparin along with postpartum anticoagulation for 4 to 6 weeks or</li>\n<li>Surveillance alone, or</li>\n<li>Prophylactic heparin + low dose aspirin (if a prior history of recurrent abortion or stillbirth)</li>\n</ul>\n</li>\n</ul>\n<p>Note: The new<strong> 2023 ACR/EULAR criteria</strong> is an update from the revised Sapporo criteria with the clinical criteria, which includes an <strong>entry criterion</strong> of at least <strong>one positive antiphospholipid antibody </strong>within three years of identification of a clinical criterion, followed by scoring with weighted criteria divided into <strong>six clinical domains</strong> (macrovascular venous thromboembolism, macrovascular arterial thrombosis, microvascular, obstetric, cardiac valve, and hematologic) and <strong>two laboratory domains</strong> (lupus anticoagulant,  IgG/IgM anticardiolipin ELISA and/or IgG/IgM anti-β2 -glycoprotein I antibodies) This has increased the <strong>specificity </strong>in diagnosing APS.</p>\n</div>\n</div>\n</div>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MF6950",
      "difficulty": "medium"
    },
    {
      "text": "Which of the following is not a cardinal finding in patients who are declared brain dead according to Harvard criteria for brain death?",
      "choices": [
        {
          "id": 1,
          "text": "No pupillary changes in response to light"
        },
        {
          "id": 2,
          "text": "Cough response to bronchial suction"
        },
        {
          "id": 3,
          "text": "Absent oculocephalic reflex"
        },
        {
          "id": 4,
          "text": "Absent eye movements in response to caloric testing"
        }
      ],
      "correct_choice_id": 2,
      "solution": "<p>Cough response to bronchial suction is indicative of <strong>normal cough reflex</strong> and is, therefore <strong>not</strong> a cardinal <strong>finding</strong> in <strong>brain death.</strong>&nbsp;</p>\n<p>The 3 <strong>cardinal features</strong> of brain death include:</p>\n<ol>\n<li><strong>Unresponsiveness</strong>&nbsp;or <strong>coma-</strong> demonstrated by an <strong>absent motor response</strong> to <strong>pain</strong> in all extremities.</li>\n<li><strong>Apnea</strong>- impaired brainstem activity indicates damage to the medullary cardio-respiratory centers. This manifests as a&nbsp;<strong>loss</strong> of <strong>centrally controlled breathing.</strong></li>\n<li><strong>Absence</strong> of<strong> brainstem reflexes</strong> -\n<ul>\n<li>Cranial nerve II, III (optic and oculomotor)- <strong>absent</strong> direct and consensual <strong>light reflex</strong>. This is associated with <strong>dilated pupils</strong> measuring about 9 mm.&nbsp;</li>\n<li>Cranial nerve VIII (vestibulocochlear)- <strong>absent</strong> oculocephalic (<em><strong>Doll's eye phenomenon</strong></em>) and <strong>oculovestibular</strong> (unresponsive to caloric testing) reflexes.</li>\n<li>Cranial nerve V, VII (trigeminal and facial)- absent corneal and jaw reflexes.</li>\n<li>Cranial nerve IX, X (glossopharyngeal and vagus)- <strong>absent cough</strong> and gag <strong>reflexes.</strong></li>\n</ul>\n</li>\n</ol><hr><h3>Related Pearl: Harvard criteria for brain death</h3><ul>\n<li>Unreceptivity and unresponsivity &nbsp; &nbsp; &nbsp;</li>\n<li>No movements &nbsp; &nbsp;</li>\n<li>Apnoea &nbsp; &nbsp; &nbsp; &nbsp;</li>\n<li>Absence of elicitable reflexes &nbsp; &nbsp; &nbsp;</li>\n<li>Isoelectric EEG (confirmatory)</li>\n</ul>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MF1129",
      "difficulty": "medium"
    },
    {
      "text": "A 58-year-old man underwent an orthopedic procedure following which he was taking multiple antibiotics. He later developed fever, diarrhoea and abdominal pain. Blood investigations reveal leukocytosis. Pseudomembranous colitis is suspected. The criteria for the diagnosis of the suspected condition includes all except?",
      "choices": [
        {
          "id": 1,
          "text": "Detection of toxin A or B in stool"
        },
        {
          "id": 2,
          "text": "Stool wet mount microscopy to visualise the organism"
        },
        {
          "id": 3,
          "text": "Diarrhea (≥3 unformed stools per 24 h for ≥2 days)"
        },
        {
          "id": 4,
          "text": "Pseudomembranes on colonoscopy or sigmoidoscopy"
        }
      ],
      "correct_choice_id": 2,
      "solution": "<p><strong>Stool wet mount microscopy</strong> to visualize the organism is <strong>not part of the criteria</strong> for the diagnosis of <strong>pseudomembranous colitis</strong></p>\n<p>Pathologically, the organism produces two toxins;&nbsp;<strong>Toxin A(Enterotoxin)</strong> causing large-volume diarrhea, and <strong>Toxin B(Cytotoxin)</strong>&nbsp;causing epithelial injury and bloody stools.</p>\n<p>The endoscopic image below shows&nbsp;<strong>pseudomembranous colitis</strong>&nbsp;caused by&nbsp;<strong>Clostridium difficile infection (CDI)</strong>.&nbsp;It is most commonly associated with the use of antimicrobials like cephalosporin, ampicillin, fluoroquinolones, clindamycin, etc.</p>\n<p>The diagnosis is based on a combination of 2 <strong>criteria</strong>:<br />1.&nbsp;Diarrhea (&ge;3 unformed stools per 24 h for &ge;2 days)<br />2. Detection of toxins A &amp; B in stools, detection of toxin-producing C. difficile by NAAT/Culture, Visualisation of the pseudomembrane in the colon.</p>\n<p>&nbsp;</p><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/de5546f0f39944d1ac821b14b4200664x720x627.JPEG\" alt=\"Explanation Image\">",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MD4925",
      "difficulty": "medium"
    },
    {
      "text": "According to Truelove–Witts criteria, which of the following is not a criterion to diagnose acute severe colitis?",
      "choices": [
        {
          "id": 1,
          "text": "Presence of jaundice and pruritus"
        },
        {
          "id": 2,
          "text": "≥ 6 bloody stools in 24 hrs"
        },
        {
          "id": 3,
          "text": "Raised inflammatory markers"
        },
        {
          "id": 4,
          "text": "Presence of anemia or fever"
        }
      ],
      "correct_choice_id": 1,
      "solution": "<p>The presence of <strong>jaundice</strong> and <strong>pruritus</strong> is not a part of&nbsp;<strong>Truelove&ndash;Witts criteria</strong> which are used to define <strong>acute severe ulcerative colitis</strong>.&nbsp;</p>\n<p><strong>Truelove&ndash;Witts criteria</strong> define <strong>acute severe colitis</strong> as the presence of:</p>\n<ol>\n<li><strong>&ge; 6 bloody stools/24 hrs</strong></li>\n<li>Plus, one or more of the following features:\n<ul>\n<li><strong>Anemia</strong> (Hemoglobin &lt;10 g/dL).</li>\n<li>Mild <strong>fever</strong> (&gt;100.04&deg;F)<strong>.</strong></li>\n<li>Tachycardia (Pulse &ge;90 beats/min).</li>\n<li><strong>High inflammatory markers</strong> (ESR &gt; 30 mm/hr <strong>or</strong>&nbsp;CRP &gt;30 mg/L).</li>\n</ul>\n</li>\n</ol>\n<p>&nbsp;</p><hr><h3>Related Pearl: Inflammatory Bowel Disease (IBD)</h3><p> </p>\n<table>\n<tbody>\n<tr>\n<td> </td>\n<td><strong>Crohn's disease</strong></td>\n<td><strong>Ulcerative colitis</strong></td>\n</tr>\n<tr>\n<td><strong>Age of onset </strong></td>\n<td>2nd-4th decades &amp; 7th-9th decades</td>\n<td>2nd-4th decades &amp; 7th-9th decades </td>\n</tr>\n<tr>\n<td><strong>Most common presentation</strong></td>\n<td>Ileocolitis with rectal sparing</td>\n<td>Proctitis (rectum)</td>\n</tr>\n<tr>\n<td><strong>Protective factors</strong></td>\n<td> None </td>\n<td>\n<p>Smoking </p>\n<p>Appendicectomy</p>\n</td>\n</tr>\n<tr>\n<td><strong>Risk factors</strong></td>\n<td>\n<p>OCP</p>\n<p>Smoking</p>\n<p>Antibiotic during first year of life </p>\n</td>\n<td>\n<p>α-Methyldopa</p>\n<p>Antibiotic during first year of life</p>\n</td>\n</tr>\n<tr>\n<td><strong>T cell involved</strong></td>\n<td>TH1 </td>\n<td>TH2</td>\n</tr>\n<tr>\n<td><strong>Gross findings/ endoscopic findings</strong></td>\n<td>\n<p>Transmural involvement</p>\n<p>Segmental involvement</p>\n<p>Skip lesions</p>\n<p>Cobblestone appearance</p>\n<p>Creeping fat</p>\n<p>Longitudinal ulcers</p>\n</td>\n<td>\n<p>Mucosal and superficial submucosal involvement </p>\n<p>Continuous involvement</p>\n<p>Pseudopolyps </p>\n<p>Backwash ileitis </p>\n<p>Collar button ulcers</p>\n</td>\n</tr>\n<tr>\n<td><strong>Earliest finding</strong></td>\n<td>Aphthous ulcer</td>\n<td>Erythematous mucosa with a fine granular surface</td>\n</tr>\n<tr>\n<td><strong>Microscopic findings </strong></td>\n<td>\n<p class=\"p1\">Deep, knife-like ulcers</p>\n<p>Granulomas</p>\n<p>Pyloric metaplasia  </p>\n</td>\n<td>\n<p class=\"p1\">Superficial, broad-based</p>\n<p>Cryptitis and crypt abscess </p>\n<p> </p>\n</td>\n</tr>\n<tr>\n<td><strong>Complications </strong></td>\n<td>\n<p>Fistulas </p>\n<p>Strictures</p>\n</td>\n<td>\n<p>Hemorrhage</p>\n<p>Toxic megacolon</p>\n</td>\n</tr>\n<tr>\n<td><strong>Recurrence after resection</strong></td>\n<td>\n<p>Common</p>\n</td>\n<td>\n<p>Uncommon, curative after resection</p>\n</td>\n</tr>\n<tr>\n<td><strong>Radiological findings </strong></td>\n<td>\n<p>Aphthous ulcer</p>\n<p>Rose thorn appearance</p>\n</td>\n<td>\n<p>Mucosal granularity</p>\n<p>Lead pipe appearance</p>\n</td>\n</tr>\n<tr>\n<td><strong>Extraintestinal manifestations</strong></td>\n<td colspan=\"2\">\n<div class=\"page\" title=\"Page 807\">\n<div class=\"page\" title=\"Page 807\">\n<div class=\"page\" title=\"Page 807\">\n<div class=\"section\">\n<div class=\"layoutArea\">\n<div class=\"column\">\n<p>Episcleritis, uveitis </p>\n<p>Migratory polyarthritis</p>\n<p>Ankylosing spondylitis, sacroiliitis</p>\n</div>\n</div>\n</div>\n</div>\n</div>\n</div>\n<div class=\"page\" title=\"Page 807\">\n<div class=\"page\" title=\"Page 807\">\n<div class=\"section\">\n<div class=\"layoutArea\">\n<div class=\"column\">\n<p>Erythema nodosum</p>\n<p>Pyoderma gangrenosum- MC in UC</p>\n<p>Primary sclerosing cholangitis- MC in UC</p>\n<p>Renal Calculi- MC in CD</p>\n</div>\n</div>\n</div>\n</div>\n</div>\n</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>\n<p><br /><br /></p>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MF8621",
      "difficulty": "medium"
    }
  ]
}